Showing 1 - 2 results of 2 for search 'Heinrich Scheiblauer', query time: 0.02s
Refine Results
-
1
German federal-state-wide seroprevalence study of 1st SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance by Stefan Lohse, Anna Sternjakob-Marthaler, Paul Lagemann, Jakob Schöpe, Jürgen Rissland, Nastasja Seiwert, Thorsten Pfuhl, Alana Müllendorff, Laurent S. Kiefer, Markus Vogelgesang, Luca Vella, Katharina Denk, Julia Vicari, Anabel Zwick, Isabelle Lang, Gero Weber, Jürgen Geisel, Jörg Rech, Bernd Schnabel, Gunter Hauptmann, Bernd Holleczek, Heinrich Scheiblauer, Stefan Wagenpfeil, Sigrun Smola
Published 2022-05-01
Article -
2
Monitoring the SARS-CoV-2 Pandemic: Prevalence of Antibodies in a Large, Repetitive Cross-Sectional Study of Blood Donors in Germany—Results from the SeBluCo Study 2020–2022 by Ruth Offergeld, Karina Preußel, Thomas Zeiler, Konstanze Aurich, Barbara I. Baumann-Baretti, Sandra Ciesek, Victor M. Corman, Viktoria Dienst, Christian Drosten, Siegfried Görg, Andreas Greinacher, Marica Grossegesse, Sebastian Haller, Hans-Gert Heuft, Natalie Hofmann, Peter A. Horn, Claudia Houareau, Ilay Gülec, Carlos Luis Jiménez Klingberg, David Juhl, Monika Lindemann, Silke Martin, Hannelore K. Neuhauser, Andreas Nitsche, Julia Ohme, Sven Peine, Ulrich J. Sachs, Lars Schaade, Richard Schäfer, Heinrich Scheiblauer, Martin Schlaud, Michael Schmidt, Markus Umhau, Tanja Vollmer, Franz F. Wagner, Lothar H. Wieler, Hendrik Wilking, Malte Ziemann, Marlow Zimmermann, Matthias an der Heiden
Published 2023-04-01
Article